AMP Capital Investors’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-93,949
Closed -$17.3M 1204
2021
Q2
$17.3M Sell
93,949
-2,041
-2% -$375K 0.08% 274
2021
Q1
$14.7M Sell
95,990
-6,049
-6% -$926K 0.07% 297
2020
Q4
$15.9M Sell
102,039
-20,072
-16% -$3.14M 0.09% 267
2020
Q3
$13.7M Sell
122,111
-15,076
-11% -$1.7M 0.08% 266
2020
Q2
$15.3M Sell
137,187
-16,823
-11% -$1.87M 0.1% 234
2020
Q1
$13.4M Sell
154,010
-5,663
-4% -$494K 0.1% 218
2019
Q4
$17.1M Buy
159,673
+43,819
+38% +$4.7M 0.09% 250
2019
Q3
$11.3M Buy
115,854
+39,904
+53% +$3.9M 0.06% 331
2019
Q2
$9.58M Sell
75,950
-4,213
-5% -$531K 0.05% 365
2019
Q1
$10.7M Buy
80,163
+11,719
+17% +$1.56M 0.06% 342
2018
Q4
$6.65M Sell
68,444
-203
-0.3% -$19.7K 0.04% 432
2018
Q3
$9.49M Sell
68,647
-27,446
-29% -$3.79M 0.05% 385
2018
Q2
$11.9M Buy
96,093
+12,565
+15% +$1.56M 0.07% 329
2018
Q1
$9.24M Sell
83,528
-13,358
-14% -$1.48M 0.05% 394
2017
Q4
$11.6M Buy
96,886
+8,525
+10% +$1.02M 0.06% 338
2017
Q3
$12.4M Buy
88,361
+9,427
+12% +$1.32M 0.07% 302
2017
Q2
$9.66M Sell
78,934
-4,399
-5% -$539K 0.06% 354
2017
Q1
$10.2M Sell
83,333
-1,700
-2% -$208K 0.06% 343
2016
Q4
$10.5M Sell
85,033
-2,219
-3% -$274K 0.06% 333
2016
Q3
$10.5M Buy
87,252
+580
+0.7% +$69.6K 0.06% 309
2016
Q2
$9.89M Buy
86,672
+2,430
+3% +$277K 0.07% 305
2016
Q1
$11.4M Sell
84,242
-33,869
-29% -$4.57M 0.08% 271
2015
Q4
$22.6M Buy
118,111
+5,627
+5% +$1.08M 0.15% 148
2015
Q3
$16.6M Buy
112,484
+5,020
+5% +$742K 0.12% 186
2015
Q2
$19.1M Buy
107,464
+40,722
+61% +$7.24M 0.12% 200
2015
Q1
$12M Sell
66,742
-32,640
-33% -$5.88M 0.07% 295
2014
Q4
$18.4M Buy
99,382
+22,954
+30% +$4.25M 0.11% 221
2014
Q3
$12.8M Buy
76,428
+3,766
+5% +$632K 0.08% 281
2014
Q2
$11.5M Buy
72,662
+14,110
+24% +$2.22M 0.07% 316
2014
Q1
$8.75M Buy
58,552
+14,600
+33% +$2.18M 0.06% 376
2013
Q4
$5.83M Buy
43,952
+7,218
+20% +$958K 0.04% 469
2013
Q3
$4.28M Sell
36,734
-41,900
-53% -$4.88M 0.03% 523
2013
Q2
$7.38M Buy
+78,634
New +$7.38M 0.06% 358